Cargando…

Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single‐Chain Antibody Specific for Activated GPIIb/IIIa

BACKGROUND: Thrombolytic therapy for acute thrombosis is limited by life‐threatening side effects such as major bleeding and neurotoxicity. New treatment options with enhanced fibrinolytic potential are therefore required. Here, we report the development of a new thrombolytic molecule that exploits...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bonnard, Thomas, Tennant, Zachary, Niego, Be'Eri, Kanojia, Ruchi, Alt, Karen, Jagdale, Shweta, Law, Lok Soon, Rigby, Sheena, Medcalf, Robert Lindsay, Peter, Karlheinz, Hagemeyer, Christoph Eugen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5523756/ https://www.ncbi.nlm.nih.gov/pubmed/28159824 http://dx.doi.org/10.1161/JAHA.116.004535

Ejemplares similares

Evidence for the selective association of a subpopulation of GPIIb-IIIa with the actin cytoskeletons of thrombin-activated platelets
Publicado: (1993)

The GPIIb-IIIa defect of platelets in Glanzmann thrombasthenia
por: Nurden, Alan T.
Publicado: (2023)

Biosynthesis and processing of platelet GPIIb-IIIa in human megakaryocytes
Publicado: (1987)

Platelet-targeted thrombolysis for treatment of acute ischemic stroke
por: Palazzolo, Jason S., et al.
Publicado: (2022)

A novel ex vivo approach for measuring plasminogen activation upon established plasma clots
por: Palazzolo, Jason S., et al.
Publicado: (2022)

Elevating local concentrations of GPIIb–IIIa antagonists counteracts platelet thrombus stability
por: Speich, Henry E., et al.
Publicado: (2012)

Construction and expression of D-dimer and GPIIb/IIIa single-chain bispecific antibody
por: DAN, ZHAOKUI, et al.
Publicado: (2013)

Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA.
por: Dardik, R., et al.
Publicado: (1998)

Design and development of ICCA as a dual inhibitor of GPIIb/IIIa and P-selectin receptors
por: Chen, Haiyan, et al.
Publicado: (2018)

Functional Comparison of Induced Pluripotent Stem Cell- and Blood-Derived GPIIbIIIa Deficient Platelets
por: Orban, Mathias, et al.
Publicado: (2015)

Eptifibatide and Cirrhosis: Rethinking GPIIb-IIIa Inhibitors for Acute Coronary Syndrome in the Setting of Liver Dysfunction
por: Weinreich, Michael, et al.
Publicado: (2014)

Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression in vitro
por: Scheinichen, Dirk, et al.
Publicado: (2004)

Platelets Induce Apoptosis during Sepsis in a Contact-Dependent Manner That Is Inhibited by GPIIb/IIIa Blockade
por: Sharron, Matthew, et al.
Publicado: (2012)

Safety of bridging antiplatelet therapy with the gpIIb-IIIa inhibitor tirofiban after emergency stenting in stroke
por: Lee, John-Ih, et al.
Publicado: (2017)

RGD-independent binding of Russell’s Viper venom Kunitz-type protease inhibitors to platelet GPIIb/IIIa receptor
por: Kalita, Bhargab, et al.
Publicado: (2019)

Uncoupling of platelet granule release and integrin activation suggests GPIIb/IIIa as a therapeutic target in COVID-19
por: Weiss, Lukas J., et al.
Publicado: (2022)

Comparison of the effects of the GPIIb-IIIa antagonist Zalunfiban and the P2Y12 antagonist Selatogrel on Platelet Aggregation
por: Curry, Benjamin J., et al.
Publicado: (2023)

Collagen‐Targeted Peptides for Molecular Imaging of Diffuse Cardiac Fibrosis
por: Ezeani, Martin, et al.
Publicado: (2021)

Shear-Dependent Platelet Aggregation: Mechanisms and Therapeutic Opportunities
por: Rana, Akshita, et al.
Publicado: (2019)

miR-204-5p and Platelet Function Regulation: Insight into a Mechanism Mediated by CDC42 and GPIIbIIIa
por: Garcia, Alix, et al.
Publicado: (2021)

Deep Vein Thrombosis Is Facilitated by Endothelial-Derived Extracellular Vesicles via the PDI–GRP94–GPIIb/IIIa Pathway in Mice
por: Lan, Hongtao, et al.
Publicado: (2023)

Assessment of the epi-pericardial fibrotic substrate by collagen-targeted probes
por: Ezeani, Martin, et al.
Publicado: (2022)

IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosis
por: Wu, Jianhui, et al.
Publicado: (2017)

Platelet Activation in Ovarian Cancer Ascites: Assessment of GPIIb/IIIa and PF4 in Small Extracellular Vesicles by Nano-Flow Cytometry Analysis
por: Bortot, Barbara, et al.
Publicado: (2022)

Platelet activation by C1q results in the induction of alpha IIb/beta 3 integrins (GPIIb-IIIa) and the expression of P-selectin and procoagulant activity
Publicado: (1993)

Development and validation of a high throughput whole blood thrombolysis plate assay
por: Bonnard, T., et al.
Publicado: (2017)

Targeting shear gradient activated von Willebrand factor by the novel single-chain antibody A1 reduces occlusive thrombus formation in vitro
por: Hoefer, Thomas, et al.
Publicado: (2020)

GPIIb/IIIa Receptor Antagonism Using Small Molecules Provides no Additive Long-Term Protection after Percutaneous Coronary Intervention as Compared to Clopidogrel Plus Aspirin
por: Schiariti, Michele, et al.
Publicado: (2010)

Decreased Platelet Specific Receptor Expression of P-Selectin and GPIIb/IIIa Predict Future Non-Surgical Bleeding in Patients after Left Ventricular Assist Device Implantation
por: Klaeske, Kristin, et al.
Publicado: (2022)

Case report: Early thrombosis in left atrial during transcatheter closure of ASD in a child with favorable outcome after use of GPIIb/IIIa receptor antagonist and heparin
por: Wang, Hui, et al.
Publicado: (2023)

LDL receptor blockade reduces mortality in a mouse model of ischaemic stroke without improving tissue-type plasminogen activator-induced brain haemorrhage: towards pre-clinical simulation of symptomatic ICH
por: Niego, Be’eri, et al.
Publicado: (2017)

The Roles of Platelet GPIIb/IIIa and αvβ3 Integrins during HeLa Cells Adhesion, Migration, and Invasion to Monolayer Endothelium under Static and Dynamic Shear Flow
por: Liu, Yiyao, et al.
Publicado: (2009)

Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study
Publicado: (1981)

t-PA Suppresses the Immune Response and Aggravates Neurological Deficit in a Murine Model of Ischemic Stroke
por: Draxler, Dominik F., et al.
Publicado: (2019)

Tissue-Type Plasminogen Activator and Tenecteplase-Mediated Increase in Blood Brain Barrier Permeability Involves Cell Intrinsic Complement
por: Keragala, Charithani B., et al.
Publicado: (2020)

Adhesion of Activated Platelets to Endothelial Cells: Evidence for a GPIIbIIIa-dependent Bridging Mechanism and Novel Roles for Endothelial Intercellular Adhesion Molecule 1 (ICAM-1), α(v)β(3) Integrin, and GPIbα
por: Bombeli, Thomas, et al.
Publicado: (1998)

Selective inhibition of brain endothelial Rho-kinase-2 provides optimal protection of an in vitro blood-brain barrier from tissue-type plasminogen activator and plasmin
por: Niego, Be’eri, et al.
Publicado: (2017)

Scanning laser-induced endothelial injury: a standardized and reproducible thrombosis model for intravital microscopy
por: Larsson, P., et al.
Publicado: (2022)

Bromomaleimide-Linked Bioconjugates Are Cleavable in Mammalian Cells
por: Moody, Paul, et al.
Publicado: (2012)

Cathepsin B-Cleavable Cyclopeptidic Chemotherapeutic Prodrugs
por: Herceg, Viktorija, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1fr79p59v0dehqrl84k8jlrkk6